CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03454451 |
Recruitment Status :
Completed
First Posted : March 6, 2018
Last Update Posted : December 21, 2023
|
Sponsor:
Corvus Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Corvus Pharmaceuticals, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | December 28, 2022 |
Actual Study Completion Date : | February 19, 2023 |